Medicine & Life Sciences
Chemoprevention
100%
Neoplasms
74%
Celecoxib
70%
Adenoma
52%
Colorectal Neoplasms
46%
Biomarkers
34%
Adenomatous Polyposis Coli
29%
Carcinogenesis
26%
Placebos
24%
National Cancer Institute (U.S.)
24%
Pharmaceutical Preparations
21%
Anti-Inflammatory Agents
21%
Eflornithine
21%
Adenocarcinoma
20%
Polyps
19%
Aspirin
19%
Barrett Esophagus
18%
Cyclooxygenase 2 Inhibitors
17%
Sulindac
16%
Early Detection of Cancer
15%
Clinical Trials
15%
Drug Development
14%
Confidence Intervals
14%
Hereditary Nonpolyposis Colorectal Neoplasms
12%
Selenomethionine
12%
sulindac sulfone
12%
Prostaglandin-Endoperoxide Synthases
12%
Hepatocellular Carcinoma
12%
Population
12%
Aberrant Crypt Foci
11%
Translational Medical Research
11%
Esophageal Neoplasms
10%
Emergency Responders
10%
Genes
10%
Therapeutics
10%
Uterine Cervical Neoplasms
10%
Incidence
9%
Colon
9%
Safety
9%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8%
Mucous Membrane
8%
Exercise
8%
Genotype
8%
Single Nucleotide Polymorphism
8%
Technology
7%
Blood Platelets
7%
Non-Steroidal Anti-Inflammatory Agents
7%
Ursodeoxycholic Acid
7%
Cyclooxygenase Inhibitors
7%
Randomized Controlled Trials
7%